Esketamine trials for Depression

5 recruiting trials study Esketamine in trials listing Depression in our tracked data. This is not a statement that it treats the condition.

Recruiting trials

Phase breakdown

Early Phase 1 1Phase 3 1Phase 4 1Not applicable 2

A Study to Evaluate the Efficacy and Safety of Esketamine for Reduction of Symptoms of Major Depressive Disorder
NCT07227454 · Phase: Phase 3 · Ages: 12 Years to 17 Years · Sex: All (male and female) · 39 locations
Long-Term Maintenance With Ketamine and Esketamine for Reduction of Suicide in High-Risk Patients With Depression
NCT05450432 · Phase: Phase 4 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 1 location
Metabolic Profiling of Esketamine Treatment in Depressive Disorder
NCT07002684 · Phase: Not specified · Ages: 18 Years to 70 Years · Sex: All (male and female) · 1 location
Personalized DBS Targeting for Treating Depression
NCT06784388 · Phase: Early Phase 1 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 1 location
University of Iowa Interventional Psychiatry Service Patient Registry
NCT04480918 · Phase: Not specified · Ages: 18 Years to 99 Years · Sex: All (male and female) · 2 locations